SCHOTT Pharma AG & Co. KGaA Statistics

Total Valuation

SCHOTT Pharma AG & Co. KGaA has a market cap or net worth of EUR 4.01 billion. The enterprise value is 4.26 billion.

Market Cap	4.01B
Enterprise Value	4.26B

Important Dates

The next estimated earnings date is Thursday, December 12, 2024.

Earnings Date	Dec 12, 2024
Ex-Dividend Date	n/a

Share Statistics

SCHOTT Pharma AG & Co. KGaA has 150.61 million shares outstanding. The number of shares has increased by 0.26% in one year.

Current Share Class	n/a
Shares Outstanding	150.61M
Shares Change (YoY)	+0.26%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	20.81%
Float	34.64M

Valuation Ratios

The trailing PE ratio is 26.67 and the forward PE ratio is 26.25. SCHOTT Pharma AG & Co. KGaA's PEG ratio is 2.31.

PE Ratio	26.67
Forward PE	26.25
PS Ratio	4.23
PB Ratio	5.16
P/TBV Ratio	n/a
P/FCF Ratio	185.38
P/OCF Ratio	n/a
PEG Ratio	2.31

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.53, with an EV/FCF ratio of 196.89.

EV / Earnings	28.31
EV / Sales	4.49
EV / EBITDA	16.53
EV / EBIT	21.65
EV / FCF	196.89

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.35.

Current Ratio	1.41
Quick Ratio	0.67
Debt / Equity	0.35
Debt / EBITDA	1.09
Debt / FCF	12.46
Interest Coverage	17.01

Financial Efficiency

Return on equity (ROE) is 21.24% and return on invested capital (ROIC) is 12.52%.

Return on Equity (ROE)	21.24%
Return on Assets (ROA)	9.12%
Return on Capital (ROIC)	12.52%
Revenue Per Employee	202,640
Profits Per Employee	32,132
Employee Count	4,646
Asset Turnover	0.74
Inventory Turnover	4.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.00%
50-Day Moving Average	29.86
200-Day Moving Average	33.17
Relative Strength Index (RSI)	30.37
Average Volume (20 Days)	39,357

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCHOTT Pharma AG & Co. KGaA had revenue of EUR 948.56 million and earned 150.41 million in profits. Earnings per share was 1.00.

Revenue	948.56M
Gross Profit	324.20M
Operating Income	186.14M
Pretax Income	174.21M
Net Income	150.41M
EBITDA	246.97M
EBIT	186.14M
Earnings Per Share (EPS)	1.00

Full Income Statement

Balance Sheet

The company has 22.15 million in cash and 269.49 million in debt, giving a net cash position of -247.34 million or -1.64 per share.

Cash & Cash Equivalents	22.15M
Total Debt	269.49M
Net Cash	-247.34M
Net Cash Per Share	-1.64
Equity (Book Value)	769.31M
Book Value Per Share	5.16
Working Capital	170.34M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 190.99 million and capital expenditures -169.37 million, giving a free cash flow of 21.63 million.

Operating Cash Flow	190.99M
Capital Expenditures	-169.37M
Free Cash Flow	21.63M
FCF Per Share	0.14

Full Cash Flow Statement

Margins

Gross margin is 34.18%, with operating and profit margins of 19.62% and 15.86%.

Gross Margin	34.18%
Operating Margin	19.62%
Pretax Margin	18.37%
Profit Margin	15.86%
EBITDA Margin	26.04%
EBIT Margin	19.62%
FCF Margin	2.28%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.57%.

Dividend Per Share	0.15
Dividend Yield	0.57%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	15.02%
Buyback Yield	-0.26%
Shareholder Yield	0.31%
Earnings Yield	3.75%
FCF Yield	0.54%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a